首页> 外文期刊>Surgical infections >Evaluation of Tigecycline Efficacy and Post-Discharge Outcomes in a Clinical Practice Population with Complicated Intra-Abdominal Infection: A Propensity Score-Matched Analysis
【24h】

Evaluation of Tigecycline Efficacy and Post-Discharge Outcomes in a Clinical Practice Population with Complicated Intra-Abdominal Infection: A Propensity Score-Matched Analysis

机译:替加环素功效和出院后结局的临床实践人群的评估与复杂的腹腔内感染:倾向得分匹配的分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background:The utility of tigecycline as compared with other antibiotic therapies in the treatment of patients with complicated intra-abdominal infection (cIAI) and the short-and long-term outcomes of a large cohort of severely ill patients were examined. We provide the first published data on post-discharge events for these patients.
机译:背景:替加环素与其他抗生素治疗相比,在治疗复杂性腹腔内感染(cIAI)和大量重症患者的短期和长期预后方面具有实用性。我们提供了这些患者出院后事件的首次公开数据。

著录项

  • 来源
    《Surgical infections》 |2016年第4期|402-411|共10页
  • 作者单位

    Univ Cincinnati, Coll Med, 231 Albert B Sabin Way, Cincinnati, OH 45267 USA;

    Univ Maryland, Sch Pharm, Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA;

    Pfizer Inc, Med Dev Grp, Collegeville, PA USA;

    Hannover Med Sch, Klinkum Peine, Acad Hosp, Peine, Germany;

    Pfizer Inc, Med Dev Grp, Collegeville, PA USA|Columbia Sch Publ Hlth, New York, NY USA;

    Indegene TTM, Kennesaw, GA USA;

    Quintiles, Cambridge, MA USA;

    Pfizer Inc, Global Innovat Pharma Business, New York, NY USA;

  • 收录信息 美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号